Solventum (SOLV) has quietly outperformed the broader market this year, with the stock up about 22% year to date, even after a recent pullback over the past week. See our latest analysis for Solventum ...

Solventum offers an interesting risk/reward profile, with improving margins, disciplined reinvestment, and potential revenue growth acceleration offsetting modest core revenue growth concerns. The ...

Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. Driven by optimism about AI and a ...

The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector ...

Valued at a market cap of $14.4 billion, Solventum Corporation (SOLV) is a Minnesota-based healthcare company, focused on delivering medical and health technology solutions. The company operates in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Hospital nurses in Newcastle are using "world-first" artificial intelligence technology to spot potentially lethal blood clots in patients more quickly than ever. New AI-technology has helped ...

Lennar is one of the largest U.S. homebuilders. Analyst Christopher Graja says Lennar shares have underperformed significantly in the past year, but that weakness could prove to be an excellent buying ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...